We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Neogen (NEOG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Read MoreHide Full Article
Neogen (NEOG - Free Report) reported $228.99 million in revenue for the quarter ended August 2023, representing a year-over-year increase of 73%. EPS of $0.11 for the same period compares to $0.15 a year ago.
The reported revenue represents a surprise of -1.23% over the Zacks Consensus Estimate of $231.85 million. With the consensus EPS estimate being $0.14, the EPS surprise was -21.43%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Neogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenues- Animal Safety: $62.71 million compared to the $73.60 million average estimate based on three analysts. The reported number represents a change of -7.4% year over year.
Revenues- Food Safety: $166.28 million compared to the $158.25 million average estimate based on three analysts. The reported number represents a change of +157.2% year over year.
Revenues- Food Safety - Culture Media & Other: $81.89 million versus $74.18 million estimated by two analysts on average.
Revenues- Animal Safety - Life Sciences: $1.66 million compared to the $1.71 million average estimate based on two analysts.
Revenues- Animal Safety - Veterinary Instruments & Disposables: $12.93 million versus the two-analyst average estimate of $16.97 million.
Revenues- Animal Safety - Animal Care & Other: $8.18 million versus $11.61 million estimated by two analysts on average.
Revenues- Food Safety - Natural Toxins, Allergens & Drug Residues: $22.27 million compared to the $25.76 million average estimate based on two analysts.
Revenues- Animal Safety - Genomics Services: $17.26 million versus the two-analyst average estimate of $6.69 million.
Revenues- Food Safety - Genomics Services: $5.81 million compared to the $21.56 million average estimate based on two analysts.
Revenues- Food Safety - Rodent Control, Insect Control & Disinfectants: $11.09 million versus $12.13 million estimated by two analysts on average.
Revenues- Food Safety - Bacterial & General Sanitation: $45.22 million versus the two-analyst average estimate of $36.89 million.
Revenues- Animal Safety - Rodent Control, Insect Control & Disinfectants: $22.69 million compared to the $24.24 million average estimate based on two analysts.
Shares of Neogen have returned -14.4% over the past month versus the Zacks S&P 500 composite's -2.6% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Neogen (NEOG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Neogen (NEOG - Free Report) reported $228.99 million in revenue for the quarter ended August 2023, representing a year-over-year increase of 73%. EPS of $0.11 for the same period compares to $0.15 a year ago.
The reported revenue represents a surprise of -1.23% over the Zacks Consensus Estimate of $231.85 million. With the consensus EPS estimate being $0.14, the EPS surprise was -21.43%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Neogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Animal Safety: $62.71 million compared to the $73.60 million average estimate based on three analysts. The reported number represents a change of -7.4% year over year.
- Revenues- Food Safety: $166.28 million compared to the $158.25 million average estimate based on three analysts. The reported number represents a change of +157.2% year over year.
- Revenues- Food Safety - Culture Media & Other: $81.89 million versus $74.18 million estimated by two analysts on average.
- Revenues- Animal Safety - Life Sciences: $1.66 million compared to the $1.71 million average estimate based on two analysts.
- Revenues- Animal Safety - Veterinary Instruments & Disposables: $12.93 million versus the two-analyst average estimate of $16.97 million.
- Revenues- Animal Safety - Animal Care & Other: $8.18 million versus $11.61 million estimated by two analysts on average.
- Revenues- Food Safety - Natural Toxins, Allergens & Drug Residues: $22.27 million compared to the $25.76 million average estimate based on two analysts.
- Revenues- Animal Safety - Genomics Services: $17.26 million versus the two-analyst average estimate of $6.69 million.
- Revenues- Food Safety - Genomics Services: $5.81 million compared to the $21.56 million average estimate based on two analysts.
- Revenues- Food Safety - Rodent Control, Insect Control & Disinfectants: $11.09 million versus $12.13 million estimated by two analysts on average.
- Revenues- Food Safety - Bacterial & General Sanitation: $45.22 million versus the two-analyst average estimate of $36.89 million.
- Revenues- Animal Safety - Rodent Control, Insect Control & Disinfectants: $22.69 million compared to the $24.24 million average estimate based on two analysts.
View all Key Company Metrics for Neogen here>>>Shares of Neogen have returned -14.4% over the past month versus the Zacks S&P 500 composite's -2.6% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term.